Effect of 8 weeks Interval Aerobic Exercise Program on Lipid Profile of Type 2 Diabetes Patients
DOI:
https://doi.org/10.37506/ijpot.v14i3.9673Keywords:
Diabetes, lipid abnormality, dyslipidemia, exercise, physical activityAbstract
Background: Lipid abnormalities are prevalent conditions in diabetic patients and predispose to atherogenic
cerebrovascular accidents thus necessitating development of rehabilitative intervention.
Objectives: To determine the effects of 8-weeks interval aerobic exercise on lipid profiles of type 2 diabetes
mellitus patients (T2 DM).
Subject and Method: All the subjects were allocated into groups using mixed sampling methods, and were
on prescribed oral hypoglycemics and diabetes exchange diet. In addition, the intervention group received
interval aerobic exercise intervention performed at sub-maximal intensity for 48minutes per session three
times per week for period of eight weeks. Hypothesis was tested using independent t-test, ANOVA and
ANCOVA and data analysed with Statistical Package for Social Sciences version 21 and alpha set at 0.05.
Results: A total of 40 (20 male and 20 females) T2 DM patients, with mean age and body mass index of
56±8years and 26±4Kg/m2 respectively participated in the study. Over 87% of the participants had at least
one form of lipid abnormality. At baseline, both groups were comparable in all the variables except age
(P<0.05), triacylglycerol (P<0.05), and very low density lipoprotein (P<0.05). Post-treatment analysis
revealed significant differences in TG (P?0.05), and high density lipoprotein (P?0.05) between exerciser and
control group, following single (30minutes) exercise bout. At the end of 8weeks, no significant difference in
lipid profiles was recorded between exercisers and the control group (P>0.05).
Conclusion: Interval aerobic exercise does not optimize reduction in lipid profiles in T2DM patients with
fairly controlled blood sugar.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Ezema CI1 , Nweke MC2 , Amarachukwu CN3 , Okafor CI4 , Uduonu EMR1 , Esom EA5
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.